FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

132211000001105: Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17713901000001110 Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17714001000001113 Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Is a Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug) true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Is a Pentasa true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Has manufactured dose form Rectal dose form true Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) 28 suppository Is pack of False Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) 28 suppository Has AMP True Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start